SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000893220-06-002687
Filing Date
2006-12-21
Accepted
2006-12-21 17:25:36
Documents
3
Period of Report
2006-12-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO. 1 PAR PHARMACEUTICAL COMPANIES, INC. w28162e8vkza.htm 8-K/A 21037
2 PRESS RELEASE DATED DECEMBER 14, 2006 w28162exv99w1.htm EX-99.1 19405
3 GRAPHIC w28162w2816201.gif GRAPHIC 5102
  Complete submission text file 0000893220-06-002687.txt   49426
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-10827 | Film No.: 061294305
SIC: 2834 Pharmaceutical Preparations